US · HYPD
Hyperion DeFi, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- New York, NY 10017
- Website
- hyperiondefi.com
Price · as of 2024-12-31
$4.18
Market cap 16.06M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $39.32 | +840.67% |
| Intrinsic Value(DCF) | $4,160.43 | +99,431.82% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $483.20 | ||||
| 2021 | $229.60 | $440.94 | $49,297,030.74 | $0.00 | $0.00 |
| 2022 | $212.80 | $100.53 | |||
| 2023 | $126.40 | $0.00 | $0.00 | ||
| 2024 | $1.59 | $39.32 | $58,232.72 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Hyperion DeFi, Inc.'s (HYPD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $39.32
- Current price
- $4.18
- AI upside
- +840.67%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$4,160.43
+99,431.82% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| HYPD | Hyperion DeFi, Inc. | $4.18 | 16.06M | +841% | +99,432% | — | — | -0.03 | -0.10 | 23.10 | -0.23 | -0.21 | -0.10 | -6749.50% | -85004.58% | -86888.57% | 2432.03% | -1558.51% | -307.07% | -0.86 | -19.62 | 0.17 | 0.13 | -0.20 | 1253.00% | 141402.00% | 890.00% | -2286.39% | -1.88 | -968.35% | 0.00% | 0.00% | 0.00% | -0.21 | -0.34 | 182.16 | -122.68 |
| BTAI | BioXcel Therapeutics, Inc… | $1.67 | 36.52M | +9,886% | -19% | — | — | -0.14 | -0.09 | 3.77 | -1.85 | — | -0.09 | 5.43% | -2967.56% | -2630.14% | 79.67% | 333.28% | -106.39% | -1.11 | -4.44 | 1.68 | 1.35 | -1.66 | -7610.00% | 6420.00% | -5354.00% | -843.12% | -3.24 | 356.98% | 0.00% | 0.00% | 0.00% | -1.21 | -1.13 | 36.03 | -28.96 |
| ECOR | electroCore, Inc. | $7.58 | 60.61M | +1,415% | +10,410% | — | — | -8.88 | 13.99 | 4.19 | -8.96 | — | 13.99 | 84.97% | -48.30% | -47.20% | -158.63% | 945.74% | -65.00% | 0.55 | — | 1.78 | 1.46 | -0.06 | -5351.00% | 5709.00% | -5329.00% | -6.59% | -0.76 | 544.51% | 0.00% | 0.00% | 0.00% | -8.03 | -14.06 | 3.88 | -7.53 |
| JSPR | Jasper Therapeutics, Inc. | $1.38 | 22.43M | — | — | — | — | -1.10 | 1.27 | — | -0.11 | — | 1.27 | 0.00% | — | — | -101.73% | 1104.03% | -81.55% | 0.03 | — | 4.98 | 4.70 | 0.93 | -2087.00% | — | 2067.00% | -80.64% | -4.11 | 914.55% | 0.00% | 0.00% | 0.00% | -0.11 | -0.13 | — | -3.88 |
| MODD | Modular Medical, Inc. | $0.25 | 15.64M | — | — | — | — | -1.66 | 1.83 | — | -1.09 | — | 1.83 | 0.00% | — | — | -131.58% | -459.49% | -115.69% | 0.05 | — | 10.69 | 10.41 | 0.71 | -3462.00% | — | 1636.00% | -58.31% | -12.43 | -439.34% | 0.00% | 0.00% | 13.57% | -1.00 | -1.04 | — | 2.40 |
| MURA | Mural Oncology plc | $2.04 | 35.38M | — | — | — | — | -0.48 | 0.44 | — | 0.60 | — | 0.44 | 0.00% | — | — | -63.57% | -2282.87% | -54.55% | 0.06 | — | 5.84 | 5.51 | 0.86 | -3902.00% | — | -3493.00% | -209.58% | -4.91 | -2123.95% | 0.00% | 0.00% | 0.00% | 0.54 | 0.58 | — | -1.84 |
| NMTC | NeuroOne Medical Technolo… | $0.67 | 33.87M | +8,902% | +225,949% | — | — | -7.93 | 4.04 | 2.36 | -7.40 | — | 4.07 | 67.30% | -34.94% | -29.80% | -91.34% | -2161.45% | -44.63% | 0.04 | -12.65 | 4.44 | 3.40 | 2.09 | -8043.00% | 25035.00% | -7378.00% | -10.21% | -1.23 | -1492.81% | 0.00% | 0.00% | 18.29% | -5.27 | -7.63 | 1.84 | -4.87 |
| PIII | P3 Health Partners Inc. | $2.12 | 6.93M | +1,116% | +75% | — | — | -0.09 | 0.35 | 0.02 | -0.78 | -0.11 | -0.05 | 100.00% | -21.37% | -9.05% | -284.66% | -147.86% | -37.75% | 2.19 | -14.46 | 0.37 | 0.33 | -0.64 | 7758.00% | 1848.00% | 4145.00% | -409.98% | -0.22 | -50.78% | 0.00% | 0.00% | 0.00% | -0.48 | -1.40 | 0.10 | -0.79 |
| RBOT | Vicarious Surgical Inc. | $2.04 | 13.19M | — | — | — | — | -0.87 | 1.17 | — | -0.32 | — | 1.17 | 0.00% | — | — | -87.40% | -511.76% | -67.41% | 0.30 | — | 6.74 | 6.40 | -0.07 | -2658.00% | — | -2163.00% | -91.59% | -6.52 | -385.51% | 0.00% | 0.00% | 0.00% | -0.29 | -0.39 | — | -4.95 |
| VRCA | Verrica Pharmaceuticals I… | $5.47 | 51.91M | +100% | -56% | — | — | -0.41 | -3.19 | 4.16 | -0.47 | — | -3.19 | 63.79% | -871.25% | -1012.15% | -1546.58% | 907.73% | -112.84% | -4.66 | -7.00 | 1.76 | 1.60 | 0.01 | 0.00% | 4766.00% | 5654.00% | -193.51% | -2.10 | 839.36% | 0.00% | 0.00% | 0.00% | -0.47 | -0.51 | 4.11 | -11.03 |
About Hyperion DeFi, Inc.
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.
- CEO
- Hyunsu Jung
- Employees
- 13
- Beta
- 2.71
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($4,160.43 ÷ $4.18) − 1 = +99,431.82% (DCF, example).